Weight Loss Improves β-Cell Function in People with Severe Obesity and Impaired Fasting Glucose: A Window of Opportunity.
In people with obesity, β-cell function may adapt to insulin resistance. We describe β-cell function in subjects with severe obesity and normal fasting glucose (NFG), impaired fasting glucose (IFG), and type 2 diabetes (T2DM) before, 3-to-6 months after, and 2-years after medical weight loss to describe its effects on insulin sensitivity, insulin secretion, and β-cell function. Fifty-eight subjects with BMI ≥35 kg/m2 (14 NFG, 24 IFG, and 20 T2DM) and 13 normal weight subjects with NFG underwent mixed meal tolerance tests to estimate insulin sensitivity (S(I)), insulin secretion (Φ), and β-cell function assessed as model-based Φ adjusted for S(I). All 58 obese subjects were restudied at 3-to-6 months and 27 were restudied at 2-years. At 3-to-6 months, after a 20 kg weight loss and a decrease in BMI of 6 kg/m2, S(I) improved in all obese subjects, Φ decreased in obese subjects with NFG and IFG and tended to decrease in obese subjects with T2DM, and β-cell function improved in obese subjects with NFG and tended to improve in obese subjects with IFG. At 2-years, β-cell function deteriorated in subjects with NFG, and T2DM but remained significantly better in subjects with IFG compared to baseline. Short-term weight loss improves β-cell function in subjects with NFG and IFG, but β-cell function tends to deteriorate over 2-years. In subjects with IFG, weight loss improves longer-term β-cell function compared to baseline and likely compared to no intervention, suggesting that obese people with IFG are a subpopulation whose β-cell function is most likely to benefit from weight loss.